Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025

Genotype-guided pharmacotherapy: the challenges of integrating pharmacogenomic testing into routine healthcare with a focus on experiences at a single site.

View Full Paper
Ask AI
Bookmark
Share

Authors

LCLarisa H. CavallariECEmily J. CicaliMNMadeline Norris

Discussion

Loading...

Member takes

Overview

Challenges of PGx testing integration in clinical settings impact drug therapy success, highlighting reimbursement and EHR issues.

Key Points

  • Pharmacogenetic testing faces integration challenges in routine healthcare, impacting drug response.
  • Evidence suggests that genetic contributions to drug response are significant, yet PGx testing remains underutilized.
  • Our institution's early adoption of PGx testing provided clinical decision support for various medications, underscoring the benefits.
  • Legislative efforts and EHR vendor improvements may enhance the integration and reimbursement of PGx testing.

Cite This Study

Cavallari et al. (2025) studied this question.

synapsesocial.com/papers/68dd89defe798ba2fc497e5fhttps://doi.org/10.1080/17512433.2025.2568089
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical pharmacogenetics implementation: Approaches, successes, and challenges2014 · 192 citations
  2. 2The State of State Biomarker Testing Insurance Coverage Laws2024 · 14 citations
  3. 3Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update2022 · 514 citations
  4. 4A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI2019 · 648 citations
  5. 5Implementation of Pharmacogenomics into the Clinical Practice of Therapeutics: Issues for the Clinician and the Laboratorian2009 · 31 citations